SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 492 filers reported holding SEAGEN INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,743 | +11.2% | 55,354 | +0.9% | 0.08% | +11.6% |
| Q2 2023 | $10,560 | +14.4% | 54,872 | +20.4% | 0.07% | +7.8% |
| Q1 2023 | $9,227 | +64.0% | 45,572 | +4.1% | 0.06% | +52.4% |
| Q4 2022 | $5,626 | -99.9% | 43,778 | -9.8% | 0.04% | -17.6% |
| Q3 2022 | $6,640,000 | -18.3% | 48,531 | +5.6% | 0.05% | -15.0% |
| Q2 2022 | $8,130,000 | +19.0% | 45,948 | -3.1% | 0.06% | +50.0% |
| Q1 2022 | $6,833,000 | -22.7% | 47,433 | -15.7% | 0.04% | -13.0% |
| Q4 2021 | $8,843,000 | +10.3% | 56,256 | +19.2% | 0.05% | +4.5% |
| Q3 2021 | $8,015,000 | +6.2% | 47,204 | -1.2% | 0.04% | -4.3% |
| Q2 2021 | $7,545,000 | -48.0% | 47,793 | -54.2% | 0.05% | -51.6% |
| Q1 2021 | $14,505,000 | +70.6% | 104,452 | +115.2% | 0.10% | +63.8% |
| Q4 2020 | $8,502,000 | – | 48,545 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |